CareLit · DOI-Nachweis · Pneumologie
Outcome of patients with primary pulmonary hypertension after listing for transplantation: benefits of therapy with iloprost and bosentan
DOI 10.1055/s-2005-864626
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Dandel, H Lehmkuhl, Y Weng, S Mulahasanovic, H Boettcher, C Knosalla, O Grauhan, C Witt, R Hetzer
ZeitschriftPneumologie
Ausgabe03/2005
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Advances in medical treatment for primary pulmonary hypertension (PPH) have improved both short- and long-term outcome of patients. However, for end-stage PPH there is controversy about long-term efficiency of this treatment and its reliability for patient withdrawal from the list for lung or heart-lung transplantation (Tx). We evaluated the benefits and safety of iloprost (prostacyclin analog) and bosentan (endothe…
Zitieren
Zitierempfehlung
M Dandel, H Lehmkuhl, Y Weng, S Mulahasanovic, H Boettcher, C Knosalla, O Grauhan, C Witt, R Hetzer (2005) Outcome of patients with primary pulmonary hypertension after listing for transplantation: benefits of therapy with iloprost and bosentan. Pneumologie (03). https://doi.org/10.1055/s-2005-864626
Mit CareLit weiterarbeiten